Our portfolio company Nestmedic, inventor and manufacturer of the telemedical CTG system Pregnabit, successfully completed the issue of shares, acquiring more than PLN 8 million from individual investors and investment funds.
The company will spend the raised capital on the development of sales in Poland and abroad, as well as on the development a second-generation version of Pregnabit. Nestmedic received already the CE and ISO 13485 certification, which allows the company to sell its product in the European Union. The company has also started the certification process in foreign markets – among other things it intends to apply for an FDA certification to the US Food and Drug Administration.
In April this year Nestmedic plans to commence trading on the NewConnect market.
Congratulations!